Lithium Citrate Syrup and Mogamulizumab-kpkc Intravenous
Determining the interaction of Lithium Citrate Syrup and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Citrate Syrup-Molindone
- Lithium Citrate Syrup-Mometasone (Oral Inhalation)
- Lithium Citrate Syrup-Mometasone and Formoterol
- Lithium Citrate Syrup-Mometasone and formoterol Inhalation
- Lithium Citrate Syrup-Mometasone Cream
- Lithium Citrate Syrup-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Lithium Controlled-Release and Extended-Release Tablets
- Mogamulizumab-kpkc Intravenous-Lithium ER
- Mogamulizumab-kpkc Intravenous-Lithium Oral Solution
- Mogamulizumab-kpkc Intravenous-Lithium Salts
- Mogamulizumab-kpkc Intravenous-Lithium Syrup and Oral Solution
- Mogamulizumab-kpkc Intravenous-Lithobid